Nippon Chemiphar Co., Ltd. (TYO:4539)
1,440.00
+2.00 (0.14%)
Apr 24, 2025, 3:23 PM JST
Nippon Chemiphar Revenue
Nippon Chemiphar had revenue of 8.68B JPY in the quarter ending December 31, 2024, with 5.45% growth. This brings the company's revenue in the last twelve months to 31.99B, up 4.49% year-over-year. In the fiscal year ending March 31, 2024, Nippon Chemiphar had annual revenue of 30.75B, down -2.57%.
Revenue (ttm)
31.99B
Revenue Growth
+4.49%
P/S Ratio
0.16
Revenue / Employee
36.06M
Employees
887
Market Cap
5.20B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 30.75B | -811.00M | -2.57% |
Mar 31, 2023 | 31.56B | -947.00M | -2.91% |
Mar 31, 2022 | 32.51B | 965.00M | 3.06% |
Mar 31, 2021 | 31.54B | -215.00M | -0.68% |
Mar 31, 2020 | 31.76B | -2.43B | -7.10% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,170.61B |
Takeda Pharmaceutical Company | 4,579.02B |
Daiichi Sankyo Company | 1,795.99B |
HOYA Corporation | 838.60B |
Terumo | 1,011.15B |
Otsuka Holdings | 2,329.86B |
Astellas Pharma | 1,867.63B |
Shionogi & | 456.87B |